Windhover Information Inc. - Health Care Business Intelligence

Windhover Information Inc. - Health Care Business Intelligence Windhover Information Inc. - Health Care Business Intelligence

What is RSS?

In3 Summit 2008 Press Release
Medtech Insight and Windhover Information’s "In3 Medical Device Summit" Investment and Partnering Conference to Feature Presentations by 60+ Early- to Late-Stage Medical Technology Companies Seeking Funding and/or Strategic Partnership. Read More.

ELSEVIER ACQUIRES WINDHOVER INFORMATION INC., A HEALTHCARE BUSINESS INTELLIGENCE COMPANY
Elsevier, the world’s leading publisher of science, technical and health information, announced today that it has acquired Windhover Information Inc., a healthcare business intelligence company that provides analysis and commentary on healthcare business strategy, industry deal making, marketplace trends and medical start-ups. Read More.

Another Dismal Year for New Drug Approvals
When does a drought stop being a drought, and just become a desert? FDA approved just 16 new molecular entities in 2007—the lowest single year total since 1983, when there were 14 NME approvals. Windhover’s own metric, Innovative Commercial Therapies, shows an even grimmer picture. Read more on The IN VIVO Blog.

Euro-Biotech 2008 Conference
Windhover Information's 15th Annual Euro-Biotech Forum is the industry's most upscale and efficient partnering meeting for American and European life science companies. Euro-Biotech delivers the companies — all handpicked by Windhover's eminent advisors — who are looking for exactly the assets you have to offer. The most active in-licensors and out-licensors will all be on hand to create future growth through investments in partnership deals! Exclusively positioned at the Hotel Arts Barcelona, Euro-Biotech offers a personal and interactive setting that combines company presentations, 1:1 meetings and European-style networking functions. To learn more, click here.

Windhover in the News: Biogen Idec
Read Roger Longman’s comment in the December 13 issue of The New York Times about Biogen Idec’s failure to sell, and the Wall Street Journal Health Blog’s take on it. Or better yet, read our Blog post from October 17 about why Biogen Idec was unlikely to sell.

Press Release: EUIQ ESP 2007 Database Released
Medtech Insight Introduces New 2007 European Surgical Procedure Volumes Database, Detailing Over 300 Procedures Across 10 Clinical Areas, including, for the First Time, Trends and Forecasts through 2009. Read more.

New Product: Windhover Launches Transaction Tracker
Windhover’s snapshot of current pharmaceutical and medical device and diagnostic dealmaking activity is now available to the industry. All year long you’ll have the most recent two months of data and analysis to keep you up-to-date on the latest deal activity and trends. PLUS you get a weekly email newsletter to alert you to the latest deal information from Windhover. Learn More

From our Strategic Transactions and Publications databases

Popular Searches
		2007 BioPharma Acquisitions
		2007 Late-Stage BioPharma Licensings
		Private Investments in Public Antibody Companies

Hot Topics
		Building Medtronic Neuro by Trial: An Interview with Richard Kuntz, MD
		Gene Therapy: The Next Big Thing?
		Flubbing the FOBs Opportunity: Follow-on Biologics Winners & Losers

Interested in subscribing? Click here.